Supplemental Injections_2019
Supplemental Injections Local Anesthesia Reversal
Instructor: Darlene O'Brien RDH, MSDHSpringfield Technical Community College
Supplemental Infiltration
Supraperiosteal injection
Used due to overlapping fibers of the contralateral inferior alveolar nerve
Also performed if PSA, MSA, ASA injections are unsuccessful
Technique:
Infiltrate into mucobuccal fold below apex of the tooth in question
Utilize a 27-gauge short needle
Administer less than 0.6 ml of solution
Gow-Gates Technique: Mandibular Nerve Block (GGMNB)
Definition:
True mandibular nerve block offering sensory anesthesia to the entire V3 (IA, L, Mental, Incisive, Buccal, Mylohyoid, Auriculotemporal nerves)
Advantages:
Higher success rate
Lower incidence of positive aspiration
Covers accessory nerve innervations not addressed by IANB
Gow-Gates Technique - Target Area
Needle Placement:
Directed toward the neck of the condyle
Accurate targeting is essential for effective anesthesia
Vazirani-Akinosi Close-Mouth Mandibular Nerve Block
Indications:
For cases where limited mandibular opening prevents use of other MD injections
Technique:
Needle inserted approximately 25 mm into tissue at the level of the maxillary mucogingival junction
Mesial to the mandibular ramus with the needle bevel facing mesially
Periodontal Ligament (PDL) Injection
Properties:
Provides anesthesia to pulp, soft tissue, and bone of a single tooth
Technique:
27-gauge short needle, bevel on root
Deposit 0.2 ml of solution over a minimum of 20 seconds
Intraseptal Injection
Purpose:
Provides osseous and soft tissue anesthesia as well as hemostasis
Insertion Area:
Located at the interdental papilla adjacent to the tooth to be treated (2mm below tip)
Technique:
27-gauge short needle with bevel toward the apex of the tooth
Insert at a 45-degree angle to the long axis of the tooth, inject a few drops before advancing until contact with bone (1-2mm), then deposit 0.2-0.4 ml over a minimum of 20 seconds
Local Anesthesia Reversal
Problem:
Lingering numbness can be inconvenient, uncomfortable, and can lead to soft tissue injury, especially in children
Patients often leave the dental office with residual numbness in lips and tongue lasting 3 to 5 hours
Indications and Contraindications for Reversal of LA
Indications:
When prolonged soft tissue anesthesia (STA) presents risks or negatively impacts lifestyle (e.g., inability to speak or eat)
Contraindications:
Post-surgical patients needing prolonged STA as pain control
Children under 6 years old or weighing less than 33 lbs
Pregnancy
Phentolamine Mesylate: OraVerse
Description:
Injectable form of phentolamine mesylate (PM) designed to terminate the numbing sensation associated with LA when no longer needed
Contains 0.4 mg PM (0.235 mg/mL) in a 1.7 mL dental cartridge
Mechanism of Action of PM
Without NV-101:
Local dental anesthetic is removed through passive diffusion into blood vessels
With NV-101:
Increases blood flow, accelerates anesthetic elimination
Clinical Effects of Phentolamine Mesylate
Effects:
Localized peripheral vasodilation
Increased perfusion at the injection site
Faster redistribution of local anesthetic from site of injection
Clinical Use of PM in Dentistry
Recommended Dosage:
Based on the number of cartridges of LA + vasoconstrictor administered
Administer in equal volume up to a maximum of 2 cartridges
Administration:
Given at the same location(s) and using the same techniques as the prior LA procedure
Median to Normal Lip Sensation
Timing Results:
Upper Lip: Median - 50 minutes (n=240), Control - 133 minutes
Lower Lip: Median - 70 minutes (n=244), Control - 155 minutes
Adverse Reactions to Phentolamine Mesylate
Possible Reactions:
Diarrhea, facial swelling, increased blood pressure/hypertension, injection site reactions, jaw pain, oral pain, tenderness, paresthesia, upper abdominal pain, vomiting
Frequency:
Majority of reactions are mild and resolve within 48 hours
Citations
Malamed, Stanley F. Handbook of Local Anesthesia, 6th Edition. Mosby Elsevier, 2013
Google Images
Designed by: Sharon L Hilton RDH, Med
Revised by: Darlene O’Brien RDH, MSDH, 2016